Teneligliptin 20mg + Metformin Hydrochloride (ER) 1000mg Tablets – MELITEN M 20/1000

Teneligliptin 20mg + Metformin Hydrochloride (ER) 1000mg Tablets  – A bilayered tablet for comprehensive and sustained control of T2DM.

MELITEN M 20/1000: The Dual combination of Teneligliptin 20 mg + Metformin 1000 mg bilayered formulation combines two potent antidiabetic agents, optimizes the release of each component, offering dual-phase action, immediate release for quick onset, and sustained release for prolonged efficacy.

Teneligliptin is a DPP-4 inhibitor that enhances glucose-dependent insulin secretion and suppresses glucagon release by increasing incretin hormone levels. This helps regulate postprandial glucose levels effectively. Metformin is a biguanide that primarily reduces hepatic glucose production, improves insulin sensitivity, and enhances peripheral glucose uptake. Its sustained-release formulation ensures a steady release, minimizing gastrointestinal side effects and ensuring better glycemic control throughout the day.

Recommended By Specialists:
Diabetologists: It is preferred to treat the disease associated with dual therapy in Type 2 diabetes
General Physicians: It is preferred to treat the disease associated with the Long-term management of diabetic patients with comorbidities

Key Benefits of Teneligliptin 20mg + Metformin Hydrochloride (ER) 1000mg Tablets – MELITEN M 20/1000
Bilayered Technology: Provides a synergistic effect with immediate and sustained drug release, improving therapeutic outcomes and patient compliance.
Dual Mechanism of Action: Combines Teneligliptin’s incretin-based action with Metformin’s glucose-lowering effects for optimal glycemic control.
Gastrointestinal Tolerance: The sustained-release formulation of Metformin reduces gastrointestinal discomfort, ensuring better patient adherence.

INDICATIONS:
Type 2 Diabetes Mellitus
Improved Glycemic Control
Metabolic Health Support